XLV
State Street Health Care Select Sector SPDR ETF·ARCA
--
--(--)
--
--(--)
Key Stats
Assets Under Management
42.25BUSD
Fund Flows (1Y)
677.39MUSD
Dividend Yield
1.57%
Discount/Premium to NAV
-0.05%
Shares Outstanding
267.02M
Expense Ratio
0.08%
About State Street Health Care Select Sector SPDR ETF
Issuer
State Street Global Advisors
Brand
SPDR
Home Page
Inception Date
Dec 16, 1998
Structure
Open-Ended Fund
Index Tracked
S&P Health Care Select Sector Index
Management Style
Passive
Dividend Treatment
Distributes
Distribution Tax Treatment
Qualified dividends
Income Tax Type
Capital Gains
Max ST Capital Gains Rate
39.60%
Max LT Capital Gains Rate
20.00%
Primary Advisor
SSgA Funds Management, Inc.
Distributor
ALPS Distributors, Inc.
XLV dominates the US health care segment on practically every measure. The fund provides exposure to companies in pharmaceuticals, health care equipment and supplies, health care providers and services, biotechnology, life sciences tools and services, and health care technology industries. XLV is the oldest in the segment, as such it is used widely for strategic or tactical positions. Since XLV is both cap weighted and fishes only from the S&P 500, it tilts heavily toward mega-caps. For focused exposure to leading health care names, XLV is tough to beat.
Classification
Asset Class
Equity
Category
Sector
Focus
Health Care
Niche
Broad-based
Strategy
Vanilla
Geography
U.S.
Weighting Scheme
Market Cap
Selection Criteria
Committee
Returns
1-Month | 3-Month | YTD | 1-Year | 3-Year | 5-Year | |
|---|---|---|---|---|---|---|
Price Performance | -1.98% | +6.66% | -0.37% | +7.13% | +23.41% | +44.85% |
NAV Total Return | -0.52% | +8.18% | +1.83% | +6.45% | +19.03% | +35.86% |
Ratings
No data is currently available
Ainvest’s AI-powered ETF Scoring Algorithm, built to help retail investors make smarter, data-driven decisions. Leveraging deep learning, reinforcement learning, and large language models, the algorithm scores ETFs across five key dimensions: Fund Flow, Momentum, Safety, Fundamentals, and Performance. Each factor is weighted by its correlation to future returns, resulting in a single, actionable score. Backtested over five years with consistently strong predictive accuracy. Ainvest brings institutional-grade artificial intelligence to everyday investors—transforming complexity into clarity with every score.
Holdings Analysis
Sector
Healthcare
100.00%
Healthcare
100.00%
Asset
Region
100%
Category
Ratio
North America
100.00%
Investment Style
Mega
Large
Medium
Multi
Small
Value
Blend
Growth
Large-Cap Growth
Focuses on large-cap companies with high growth potential. These ETFs invest in leading companies with strong expansion prospects.
Top 10 Holdings
Symbol
Ratio
LLY
Eli Lilly
15.56%
JNJ
Johnson & Johnson
10.00%
ABBV
Abbvie
6.79%
MRK
Merck
5.20%
UNH
UnitedHealth Group
4.42%
TMO
Thermo Fisher
3.76%
AMGN
Amgen
3.49%
ABT
Abbott Laboratories
3.33%
GILD
Gilead Sciences
3.21%
ISRG
Intuitive Surgical
3.00%
Top 10 Weight 58.75%
63 Total Holdings
Is SPY better than XLV?
Dividends
Dividend Payout History
Declaration Date | Record Date | Payment Date | Amount |
|---|---|---|---|
| 2025-12-22 | 2025-12-22 | 2025-12-24 | 0.657 |
| 2025-09-22 | 2025-09-22 | 2025-09-24 | 0.625 |
| 2025-06-23 | 2025-06-23 | 2025-06-25 | 0.630 |
| 2025-03-24 | 2025-03-24 | 2025-03-26 | 0.565 |
| 2024-12-23 | 2024-12-23 | 2024-12-26 | 0.622 |
| 2024-09-23 | 2024-09-23 | 2024-09-25 | 0.577 |
| 2024-06-24 | 2024-06-24 | 2024-06-26 | 0.573 |
Show more
How Much Does XLV Pay in Dividends?
Premium/Discount Chart
Assets Under Management
Should I buy XLV?
Fund Flows
